|
Who's Developing What in Drug Delivery?Published by: Espicom Healthcare Intelligence Published: Oct. 9, 2008 - 680 Pages Table of Contents
AbstractThe indispensible 2-volume guide to the companies that are shaping this critical area.The importance of drug delivery technology grows ever more acute and commercial, and industry interest is continuing to build. The benefits to patients can be seen through improved medical outcomes, while the pharmaceutical industry is able to bring new products to market and extend patent protection through novel delivery regimes, and bring new therapies to the market that would previously have been impossible. Consequently, the drug delivery sector has evolved from being simply a part of the pharmaceutical production process to a driving force for innovation and profits. As a result, developers of drug delivery products and technology have benefited from significant attention from customers and investors alike, and merger and acquisition activity is notable. Who’s Developing What in Drug Delivery? is a new 680+ page management report (expanded 4th edition, published October 2008) that provides comprehensive analysis of 135 leading players in the drug delivery field. “By 2015 sales of products using advanced drug delivery technology assessed could exceed US$43 billion.” Key features and benefits... Detailed review of 134 leading companies in the field Comprehensive coverage of each company’s technology focus, products, R&D and deals International coverage - companies from across the world reviewed All major drug-delivery technologies covered including: - Controlled-release - Nucleic acid - Nano-enabled - Targeted Please note, this file is delivered as a Zip file. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||